GSTM1 and esophageal squamous cell carcinoma: In summary, we determined preoperative Alb ≦41.2 g/L, LA diameter >32.9 mm, preoperative Hb >149 g/L, and EF >67.61% to be the risk factors for POAF among patients with ESCC receiving neoadjuvant therapy and MIE.